Clinical Trial Results:
A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED PARALLEL GROUP
STUDY OF THE EFFICACY AND SAFETY OF 4 ADMINISTRATIONS OF
XRP0038/NV1FGF 4mg AT 2–WEEK INTERVALS ON AMPUTATION OR ANY DEATH
IN CRITICAL LIMB ISCHEMIA PATIENTS WITH SKIN LESIONS
Summary
|
|
EudraCT number |
2006-006277-24 |
Trial protocol |
DE BE HU GB CZ GR ES AT FI SE FR EE IT DK NL |
Global completion date |
08 Aug 2012
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
26 Oct 2016
|
First version publication date |
26 Oct 2016
|
Other versions |
|
Summary report(s) |
EFC6145 |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.